XON7 for advanced or metastatic solid tumors
Part of Cancer clinical trials.
This trial tests an experimental drug called XON7 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if XON7 is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older with advanced or metastatic solid tumors (certain types for phase 2).
- Your cancer must have progressed after no more than 4 prior treatments, or you cannot have standard therapy.
- You need to be in good enough health to perform daily activities (ECOG 0-1) and have a life expectancy of at least 12 weeks.
- You cannot have certain conditions like autoimmune disease, active infections, or recent heart problems.
- You must agree to use effective contraception during the study and for 60 days after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1/2 trial tests XTX301, a study treatment, in people with advanced solid tumors (cancers) that have already been treated and are not controlled by standard options. It may help if your cancer matches one of the study groups and you meet safety and test-tissue requirements.
This trial tests a new drug, XTX501, for people with advanced non-small cell lung cancer or other solid tumors. It aims to see if the drug can help shrink tumors or slow their growth.
This Phase 1 study tests XZB-0004 in adults with solid cancers to check safety and how the body responds to the drug. It may help doctors learn whether this treatment could be useful for certain tumor types, including non-small cell lung cancer.
This trial tests a new drug called XNW29016 for people with advanced cancer that has stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
This trial tests a new drug called XNW34017 for people with advanced solid tumors, including small cell lung cancer and prostate cancer. It may be an option if you've tried other treatments that no longer work.
This trial tests a new injection, YB1-X7, for people with advanced solid tumors that haven't responded to standard treatments. The injection is given directly into a tumor, and the goal is to see if it can help shrink tumors or slow their growth.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.